carnitine has been researched along with Critical Illness in 18 studies
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Both levocarnitine and lactulose, either alone or in combination, have been used for the treatment of hyperammonemia associated with valproic acid, however they have not been directly compared in the literature." | 8.02 | Evaluation of levocarnitine, lactulose, and combination therapy for the treatment of valproic acid-induced hyperammonemia in critically ill patients. ( Cunningham, B; Fowler, M; Mullen, C; Nicholson, C, 2021) |
| " We investigated the effects of L-carnitine adjunctive therapy on monitoring variables in critical illness." | 5.69 | The effects of adjunctive treatment with L-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial. ( Badpeyma, M; Bagherniya, M; Clark, CCT; Feizi, A; Keshani, M; Norouzy, A; Safarian, M; Sedaghat, A; Yahyapoor, F, 2023) |
| "The aim of this study was to evaluate to what extent secondary carnitine deficiency may exist based on the prevalence of subnormal carnitine status in patients with critical illness and abnormal nutritional state." | 5.07 | Prevalence of carnitine depletion in critically ill patients with undernutrition. ( Arfvidsson, B; Hyltander, A; Lundholm, K; Sandström, R; Sjöberg, A; Wennberg, A; Wickström, I, 1992) |
| " This article reviews some of the pharmacologic roles that parenteral nutritional ingredients (selenium, lipid emulsion, insulin, and levocarnitine) can play in the setting of critical illness." | 4.90 | Nutrition as medical therapy. ( DiNapoli, M; Miller, MA; Ross, B; Yogaratnam, D, 2014) |
| " Perioperative metabolic conditioning using glutamine and L-carnitine may be used to modulate insulin sensitivity but further studies need to determine whether these interventions result in clinical benefit." | 4.88 | Metabolic conditioning to attenuate the adverse effects of perioperative fasting and improve patient outcomes. ( Awad, S; Lobo, DN, 2012) |
| " The aim of this study was to describe and compare the prevalence of micronutrient and carnitine deficiencies in critically ill patients at high malnutrition risk exposed to CRRT to a group of patient unexposed to CRRT." | 4.12 | Micronutrient deficiencies in critically ill patients receiving continuous renal replacement therapy. ( Fah, M; Haines, KL; Krishnamoorthy, V; Ohnuma, T; Raghunathan, K; Van Althuis, LE; Williams, DGA; Winthrop, HM; Wischmeyer, PE, 2022) |
| " Both levocarnitine and lactulose, either alone or in combination, have been used for the treatment of hyperammonemia associated with valproic acid, however they have not been directly compared in the literature." | 4.02 | Evaluation of levocarnitine, lactulose, and combination therapy for the treatment of valproic acid-induced hyperammonemia in critically ill patients. ( Cunningham, B; Fowler, M; Mullen, C; Nicholson, C, 2021) |
| "l-Carnitine (3000 mg/day) was administered via nasogastric tube for the intervention group for 7 days, while the other group received a placebo for the same duration." | 3.11 | The effects of l-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial. ( Arabi, SM; Bagherniya, M; Feizi, A; Islam, MS; Khadem-Rezaiyan, M; Norouzy, A; Pahlavani, N; Safarian, M; Sedaghat, A; Yahyapoor, F; Zarifi, SH, 2022) |
| "Carnitine is a small molecule essential for fatty acid oxidation and gluconeogenesis." | 1.62 | Carnitine deficiency among hospitalized pediatric patients: A retrospective study of critically ill patients receiving extracorporeal membrane oxygenation therapy. ( Kelley, J; Kellogg, K; Norris, M; Parietti, J; Scott, AI; Sullivan, E; Sullivan, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nicholson, C | 1 |
| Fowler, M | 1 |
| Mullen, C | 1 |
| Cunningham, B | 1 |
| Yahyapoor, F | 2 |
| Sedaghat, A | 2 |
| Feizi, A | 2 |
| Bagherniya, M | 2 |
| Pahlavani, N | 1 |
| Khadem-Rezaiyan, M | 1 |
| Safarian, M | 2 |
| Islam, MS | 1 |
| Zarifi, SH | 1 |
| Arabi, SM | 1 |
| Norouzy, A | 2 |
| Fah, M | 1 |
| Van Althuis, LE | 1 |
| Ohnuma, T | 1 |
| Winthrop, HM | 1 |
| Haines, KL | 1 |
| Williams, DGA | 1 |
| Krishnamoorthy, V | 1 |
| Raghunathan, K | 1 |
| Wischmeyer, PE | 1 |
| Keshani, M | 1 |
| Clark, CCT | 1 |
| Badpeyma, M | 1 |
| Wilkinson, D | 1 |
| Gallagher, IJ | 1 |
| McNelly, A | 1 |
| Bear, DE | 1 |
| Hart, N | 1 |
| Montgomery, HE | 1 |
| Le Guennec, A | 1 |
| Conte, MR | 1 |
| Francis, T | 1 |
| Harridge, SDR | 1 |
| Atherton, PJ | 1 |
| Puthucheary, ZA | 1 |
| Kelley, J | 1 |
| Sullivan, E | 1 |
| Norris, M | 1 |
| Sullivan, S | 1 |
| Parietti, J | 1 |
| Kellogg, K | 1 |
| Scott, AI | 1 |
| Giva, S | 1 |
| Finnegan, J | 1 |
| Ihidero, P | 1 |
| Maguire, G | 1 |
| Power, B | 1 |
| Knerr, I | 1 |
| Monavari, A | 1 |
| Casaer, MP | 1 |
| Bellomo, R | 1 |
| Bonafé, L | 1 |
| Berger, MM | 1 |
| Que, YA | 1 |
| Mechanick, JI | 1 |
| Yogaratnam, D | 1 |
| Miller, MA | 1 |
| Ross, B | 1 |
| DiNapoli, M | 1 |
| Zhou, Z | 1 |
| Qiu, C | 2 |
| Chen, C | 2 |
| Wang, L | 1 |
| Chen, J | 2 |
| Chen, M | 2 |
| Guan, X | 2 |
| Ouyang, B | 2 |
| Zhang, W | 1 |
| Kou, Q | 1 |
| Wu, S | 1 |
| Zhou, L | 1 |
| Liu, J | 1 |
| Ma, G | 1 |
| Luo, H | 1 |
| Zhang, X | 1 |
| Lai, J | 1 |
| Yu, Z | 1 |
| Yu, X | 1 |
| Liao, W | 1 |
| Awad, S | 1 |
| Lobo, DN | 1 |
| Ball, MJ | 1 |
| Proulx, F | 1 |
| Lacroix, J | 1 |
| Qureshi, IA | 1 |
| Nadeau, D | 1 |
| Gauthier, M | 1 |
| Lambert, M | 1 |
| Nijveldt, RJ | 1 |
| Tan, AM | 1 |
| Prins, HA | 1 |
| de Jong, D | 1 |
| van Rij, GL | 1 |
| Wesdorp, RI | 1 |
| van Leeuwen, PA | 1 |
| Wennberg, A | 1 |
| Hyltander, A | 1 |
| Sjöberg, A | 1 |
| Arfvidsson, B | 1 |
| Sandström, R | 1 |
| Wickström, I | 1 |
| Lundholm, K | 1 |
| Scholten, DJ | 1 |
| Davis, AT | 1 |
| Albrecht, RM | 1 |
| Morgan, RE | 1 |
3 reviews available for carnitine and Critical Illness
| Article | Year |
|---|---|
Carnitine deficiency in chronic critical illness.
Topics: Cardiomyopathies; Carnitine; Chronic Disease; Critical Illness; Fatty Acids; Humans; Hyperammonemia; | 2014 |
Nutrition as medical therapy.
Topics: Carnitine; Critical Care Nursing; Critical Illness; Humans; Insulin; Lipids; Nutrition Therapy; Pare | 2014 |
Metabolic conditioning to attenuate the adverse effects of perioperative fasting and improve patient outcomes.
Topics: Arginine; Carbohydrate Metabolism; Carnitine; Critical Illness; Dietary Supplements; Elective Surgic | 2012 |
7 trials available for carnitine and Critical Illness
| Article | Year |
|---|---|
The effects of l-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial.
Topics: Biomarkers; C-Reactive Protein; Carnitine; Critical Illness; Dietary Supplements; Humans; Interleuki | 2022 |
The effects of adjunctive treatment with L-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial.
Topics: Carnitine; COVID-19; Critical Illness; Humans; Intensive Care Units; Iran; Lactates; Prospective Stu | 2023 |
The metabolic effects of intermittent versus continuous feeding in critically ill patients.
Topics: Alanine; Amino Acids; Carnitine; Critical Illness; Humans; Ketones | 2023 |
Fat-Modified Enteral Formula Improves Feeding Tolerance in Critically Ill Patients: A Multicenter, Single-Blind, Randomized Controlled Trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Bilir | 2017 |
Parenteral nutrition in the critically ill: use of a medium chain triglyceride emulsion.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Aged; Blood Cell Count; Carnitine; Critical Illness; Dr | 1993 |
Use of a mixture of medium-chain triglycerides and longchain triglycerides versus long-chain triglycerides in critically ill surgical patients: a randomized prospective double-blind study.
Topics: Adult; Aged; Bilirubin; Carnitine; Critical Illness; Double-Blind Method; Energy Intake; Energy Meta | 1998 |
Prevalence of carnitine depletion in critically ill patients with undernutrition.
Topics: Aged; Carnitine; Critical Illness; Female; Hemofiltration; Humans; Kidney Diseases; Liver Diseases; | 1992 |
8 other studies available for carnitine and Critical Illness
| Article | Year |
|---|---|
Evaluation of levocarnitine, lactulose, and combination therapy for the treatment of valproic acid-induced hyperammonemia in critically ill patients.
Topics: Carnitine; Cohort Studies; Critical Illness; Humans; Hyperammonemia; Lactulose; Retrospective Studie | 2021 |
Micronutrient deficiencies in critically ill patients receiving continuous renal replacement therapy.
Topics: Carnitine; Continuous Renal Replacement Therapy; Copper; Critical Illness; Humans; Malnutrition; Mic | 2022 |
Carnitine deficiency among hospitalized pediatric patients: A retrospective study of critically ill patients receiving extracorporeal membrane oxygenation therapy.
Topics: Carnitine; Child; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Infant; Malnutritio | 2021 |
Hyperammonaemia in Neonates and Young Children: Potential Metabolic Causes, Diagnostic Approaches and Clinical Consequences
Topics: Ammonia; Arginine; Biomarkers; Brain Diseases, Metabolic, Inborn; Carnitine; Critical Illness; Diet, | 2019 |
Micronutrient deficiency in critical illness: an invisible foe?
Topics: Ascorbic Acid Deficiency; Carnitine; Critical Illness; Folic Acid; Humans; Micronutrients; Nutrition | 2019 |
[Related factor of serum carnitine deficiency and influence of its deficiency on the length of hospital stay in critical ill patients].
Topics: APACHE; Bilirubin; Carnitine; Critical Illness; Enteral Nutrition; Hospital Mortality; Humans; Inten | 2014 |
Acquired carnitine abnormalities in critically ill children.
Topics: Adolescent; Biomarkers; Carnitine; Child; Child, Preschool; Critical Illness; Energy Intake; Female; | 1997 |
Carnitine femoral arterial-venous differences in the stressed critically ill.
Topics: Adult; Aged; Carnitine; Critical Illness; Female; Femoral Artery; Femoral Vein; Humans; Male; Middle | 1989 |